Artificial Intelligence is fastest growing segment fueling the growth of Non-Small Cell Lung Cancer Market
The global Non-Small Cell Lung Cancer Market is estimated to be valued at US$ 27,252.31 Mn in 2023 and is expected to exhibit a CAGR of 9.4% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Overview: Non-small cell lung cancer (NSCLC) is the most common type of lung cancer. It develops in the cells lining the alveoli in the lungs. NSCLC comprises approximately 85% of all lung cancers and includes adenocarcinoma, squamous cell carcinoma, and large cell carcinoma. Early detection of NSCLC is crucial for improved treatment outcomes. Market key trends: Emerging new technologies for NSCLC diagnosis and treatment, such as artificial intelligence, are contributing significantly to the growth of the non-small cell lung cancer market. Artificial intelligence algorithms can analyze complex medical imaging data, like CT scans, and detect lung cancers with high accuracy. They also provide prognosis of cancer stages which helps...